issued
on 20 Feb 2024
Last Applicant/ Owned by
30 Florida Ave., N. W., Unit #6
Washington, D. C.
DC
20001
Serial Number
90862596 filed on 03rd Aug 2021
Registration Number
N/A
Correspondent Address
Francis G. Gleason Jr.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"THE SUSTAINABLE HEALTHCARE COMPANY"
Providing temporary use of on-line non-downloadable software and applications for use in obtaining prescription and over the counter medications and referrals to healthcare providers "THE SUSTAINABLE HEALTHCARE COMPANY" Hygienic and beauty care; Medical services; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing a web site featuriRead More
Hygienic and beauty care; Medical services; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing a web site featuring information in the field of mental health and physical health, including living a healthy and disease free life; Provision of health care and medical services by health care professionals via the Internet or telecommunication networks
Providing temporary use of on-line non-downloadable software and applications for use in obtaining prescription and over the counter medications and referrals to healthcare providers
Providing a website featuring blogs and non-downloadable publications in the nature of magazines, brochures, and articles in the field(s) of pharmaceuticals, medicine, healthcare, disease management, nutrition, diet, fitness, and personal health
Retail pharmacy services; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies
Downloadable mobile applications for featuring pricing information for prescription drugs and over the counter medications, for purchasing of prescription drugs and over the counter medications, and for providing information regarding health, prescription drugs and over the counter medications; Downloadable mobile applications for use in obtaining prescription and over the counter medications and referrals to healthcare providers; Downloadable software in the nature of a mobile application for use in connection with the collection, analysis, and sharing of personal medical data
Analgesic and muscle relaxant pharmaceutical preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent swelling in the legs
No 90862596
No Service Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 20th Feb 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 26th Dec 2023 | PUBLISHED FOR OPPOSITION |
| 26th Dec 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 06th Dec 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 20th Nov 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 08th May 2023 | SUSPENSION LETTER WRITTEN |
| 08th May 2023 | LETTER OF SUSPENSION E-MAILED |
| 08th May 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 20th Apr 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 20th Apr 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
